I carcinomi di intervallo quali indicatori di performance di un programma di screening

Stefano Ciatto; Carlo Naldoni; Antonio Ponti; Livia Giordano; Daniela Giorgi; Alfonso Frigerio; Marcello Vettorazzi; Lauro Bucchi; Luigi Bisanti; Marco Petrella; Eugenio Paci; Gianni Saguatti; Dolores Santini; Marco Rosselli Del Turco; Marco Zappa; Paolo Giorgi Rossi; Vittorio Corsetti; Luisella Milanesio; Priscilla Sassoli De'Bianchi

I carcinomi di intervallo quali indicatori di performance di un programma di screening

Translated title of the contribution: Interval cancers as indicators of performance in screening programmes

Stefano Ciatto, Carlo Naldoni, Antonio Ponti, Livia Giordano, Daniela Giorgi, Alfonso Frigerio, Marcello Vettorazzi, Lauro Bucchi, Luigi Bisanti, Marco Petrella, Eugenio Paci, Gianni Saguatti, Dolores Santini, Marco Rosselli Del Turco, Marco Zappa, Paolo Giorgi Rossi, Vittorio Corsetti, Luisella Milanesio, Priscilla Sassoli De'Bianchi

Research output: Contribution to journal › Article › peer-review

Abstract

GISMa analyses the interval cancer (IS) topic providing guidelines and reference standards in addition to CE recommendations. IC identification is based on Cancer Registries (CR), if existing, or on hospital discharge records, in alternative. The optimal measure of IC frequency (inversely correlated with sensitivity) is the IC proportional incidence (observed IC I carcinomas expected in absence of screening). Otherformulas (ICIIC + screen detected cancers; IC rate per 1,000 negative screens) look less reliable. IC stage at diagnosis (if available through CR) must be compared with screen detected cancer and cancer detected in non-attenders. Review of mammograms preceding the IC (coded as screening error, minimal signs, or occult) should be done mainly with a blind procedure (IC mixed with negative controls), as this procedure is more representative ofthe original scenario and more respectful of radiologist's rights.

Translated title of the contribution	Interval cancers as indicators of performance in screening programmes
Original language	Italian
Pages (from-to)	93-98
Number of pages	6
Journal	Epidemiologia e prevenzione
Volume	32
Issue number	2
Publication status	Published - Mar 2008

ASJC Scopus subject areas

Epidemiology
Public Health, Environmental and Occupational Health

Cite this

Ciatto, S., Naldoni, C., Ponti, A., Giordano, L., Giorgi, D., Frigerio, A., Vettorazzi, M., Bucchi, L., Bisanti, L., Petrella, M., Paci, E., Saguatti, G., Santini, D., Del Turco, M. R., Zappa, M., Rossi, P. G., Corsetti, V., Milanesio, L., & De'Bianchi, P. S. (2008). I carcinomi di intervallo quali indicatori di performance di un programma di screening. Epidemiologia e prevenzione, 32(2), 93-98.

Ciatto, S, Naldoni, C, Ponti, A, Giordano, L, Giorgi, D, Frigerio, A, Vettorazzi, M, Bucchi, L, Bisanti, L, Petrella, M, Paci, E, Saguatti, G, Santini, D, Del Turco, MR, Zappa, M, Rossi, PG, Corsetti, V, Milanesio, L & De'Bianchi, PS 2008, 'I carcinomi di intervallo quali indicatori di performance di un programma di screening', Epidemiologia e prevenzione, vol. 32, no. 2, pp. 93-98.

@article{b5e718fb5ee9409e9a8607d1c15f8825,

title = "I carcinomi di intervallo quali indicatori di performance di un programma di screening",

abstract = "GISMa analyses the interval cancer (IS) topic providing guidelines and reference standards in addition to CE recommendations. IC identification is based on Cancer Registries (CR), if existing, or on hospital discharge records, in alternative. The optimal measure of IC frequency (inversely correlated with sensitivity) is the IC proportional incidence (observed IC I carcinomas expected in absence of screening). Otherformulas (ICIIC + screen detected cancers; IC rate per 1,000 negative screens) look less reliable. IC stage at diagnosis (if available through CR) must be compared with screen detected cancer and cancer detected in non-attenders. Review of mammograms preceding the IC (coded as screening error, minimal signs, or occult) should be done mainly with a blind procedure (IC mixed with negative controls), as this procedure is more representative ofthe original scenario and more respectful of radiologist's rights.",

keywords = "Breast cancer, Diagnosis, Screening interval cancer",

author = "Stefano Ciatto and Carlo Naldoni and Antonio Ponti and Livia Giordano and Daniela Giorgi and Alfonso Frigerio and Marcello Vettorazzi and Lauro Bucchi and Luigi Bisanti and Marco Petrella and Eugenio Paci and Gianni Saguatti and Dolores Santini and {Del Turco}, {Marco Rosselli} and Marco Zappa and Rossi, {Paolo Giorgi} and Vittorio Corsetti and Luisella Milanesio and De'Bianchi, {Priscilla Sassoli}",

year = "2008",

month = mar,

language = "Italian",

volume = "32",

pages = "93--98",

journal = "Epidemiologia e prevenzione",

issn = "1120-9763",

publisher = "Zadig s.r.l",

number = "2",

}

TY - JOUR

T1 - I carcinomi di intervallo quali indicatori di performance di un programma di screening

AU - Ciatto, Stefano

AU - Naldoni, Carlo

AU - Ponti, Antonio

AU - Giordano, Livia

AU - Giorgi, Daniela

AU - Frigerio, Alfonso

AU - Vettorazzi, Marcello

AU - Bucchi, Lauro

AU - Bisanti, Luigi

AU - Petrella, Marco

AU - Paci, Eugenio

AU - Saguatti, Gianni

AU - Santini, Dolores

AU - Del Turco, Marco Rosselli

AU - Zappa, Marco

AU - Rossi, Paolo Giorgi

AU - Corsetti, Vittorio

AU - Milanesio, Luisella

AU - De'Bianchi, Priscilla Sassoli

PY - 2008/3

Y1 - 2008/3

N2 - GISMa analyses the interval cancer (IS) topic providing guidelines and reference standards in addition to CE recommendations. IC identification is based on Cancer Registries (CR), if existing, or on hospital discharge records, in alternative. The optimal measure of IC frequency (inversely correlated with sensitivity) is the IC proportional incidence (observed IC I carcinomas expected in absence of screening). Otherformulas (ICIIC + screen detected cancers; IC rate per 1,000 negative screens) look less reliable. IC stage at diagnosis (if available through CR) must be compared with screen detected cancer and cancer detected in non-attenders. Review of mammograms preceding the IC (coded as screening error, minimal signs, or occult) should be done mainly with a blind procedure (IC mixed with negative controls), as this procedure is more representative ofthe original scenario and more respectful of radiologist's rights.

AB - GISMa analyses the interval cancer (IS) topic providing guidelines and reference standards in addition to CE recommendations. IC identification is based on Cancer Registries (CR), if existing, or on hospital discharge records, in alternative. The optimal measure of IC frequency (inversely correlated with sensitivity) is the IC proportional incidence (observed IC I carcinomas expected in absence of screening). Otherformulas (ICIIC + screen detected cancers; IC rate per 1,000 negative screens) look less reliable. IC stage at diagnosis (if available through CR) must be compared with screen detected cancer and cancer detected in non-attenders. Review of mammograms preceding the IC (coded as screening error, minimal signs, or occult) should be done mainly with a blind procedure (IC mixed with negative controls), as this procedure is more representative ofthe original scenario and more respectful of radiologist's rights.

KW - Breast cancer

KW - Diagnosis

KW - Screening interval cancer

UR - http://www.scopus.com/inward/record.url?scp=54449102090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54449102090&partnerID=8YFLogxK

M3 - Articolo

C2 - 18717231

AN - SCOPUS:54449102090

VL - 32

SP - 93

EP - 98

JO - Epidemiologia e prevenzione

JF - Epidemiologia e prevenzione

SN - 1120-9763

IS - 2

ER -

I carcinomi di intervallo quali indicatori di performance di un programma di screening

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this